• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Avicanna Inc (OP:AVCNF)

0.0709 UNCHANGED
Delayed Quote Updated: 3:24 PM EDT, Oct 22, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 0.0709
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 0.0709
Today's Range 0.0709 - 0.0709
52wk Range 0.0596 - 0.1953
Shares Outstanding N/A
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Life Sciences Virtual Investor Forum Presentations Now Available for On-Demand Viewing
September 18, 2026
Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com 
From Virtual Investor Conferences
Via GlobeNewswire
News headline image
Life Sciences Virtual Investor Forum Agenda Announced
September 14, 2026
Company executives will discuss their business strategies, provide updates on recent developments, and answer questions live from investors. 
From Virtual Investor Conferences
Via GlobeNewswire

Performance

52-Week Range 63.7% below 52-week high
0.0709
0.0652W Low 0.2052W High
1 Week 6.0% below 1-week high
0.071W Low 0.081W High

Avicanna Inc (AVCNF) traded between $0.06 and $0.20 over the past 52 weeks and last traded at $0.07, 63.7% below its 52-week high. Over the past week it ranged between $0.07 and $0.08.

Past 12 Months
-6.0%
-1.0%
-26.1%
-37.9%
-57.8%
-62.1%
1W -$0.00
1M -$0.00
3M -$0.03
6M -$0.04
YTD -$0.10
1Y -$0.12

AVCNF was -62.1% over the past year, -37.9% over six months, -57.8% year to date, -6.0% in the last week.

12 Months vs Market
AVCNF
-62.1%
DIA
+13.3%
SPY
+14.4%
QQQ
+16.3%
IWM
+13.7%

Over the past 12 months AVCNF returned -62.1% versus DIA (Dow) +13.3%, SPY (S&P 500) +14.4%, QQQ (Nasdaq 100) +16.3% and IWM (Russell 2000) +13.7%.

Volume & Liquidity
1W
425.0
1M
38.3K
3M
69.8K
6M
84.5K
YTD
72.4K
1Y
65.1K

AVCNF's 3-month average daily volume is 69.8K.

More News

Read More
News headline image
Life Sciences Virtual Investor Forum Presentations Now Available for Online Viewing
March 13, 2026
From Virtual Investor Conferences
Via GlobeNewswire
News headline image
Life Sciences Virtual Investor Forum Agenda Announced for March 11th & 12th
March 10, 2026
From Virtual Investor Conferences
Via GlobeNewswire
News headline image
World's Largest Tobacco Company Is Investing In Medical Cannabis: Here's What To Know ↗
May 13, 2025
Via Benzinga
Topics Cannabis
News headline image
This Week In Cannabis: Carmelo's NY Launch, Federal Reform, Cancer Study, Avicanna's Growth, Tilray's Split, DeSantis Fallout, Slovenia's Big Move And More ↗
April 18, 2025
Via Benzinga
Topics Cannabis
News headline image
Why Cannabis-Focused Biopharma Co. Avicanna Traded Up 26%+ Today ↗
April 14, 2025
Via Benzinga
News headline image
The Week In Cannabis: Delays, Decrees And Deals Reshape The Global Playbook ↗
April 11, 2025
Via Benzinga
Topics Cannabis
News headline image
Life Science Virtual Investor Forum: Presentations Now Available for Online Viewing
March 14, 2025
From Virtual Investor Conferences
Via GlobeNewswire
News headline image
Life Sciences Investor Forum Agenda Announced for March 13th
March 12, 2025
From Virtual Investor Conferences
Via GlobeNewswire
News headline image
This Week In Cannabis: Rescheduling Delays, The DEA, Biden's Clemency, Philip Morris' New Bet And More ↗
January 17, 2025
Via Benzinga
Topics Cannabis
News headline image
Avicanna Reduces Net Loss And Improves Gross Profit, Focusing On International Markets ↗
November 15, 2024
Via Benzinga
News headline image
Cannabis Flower Sales In Colombia And The Small Producer Protection Myth: Ex-Official Says Most Companies Qualify ↗
October 24, 2024
Via Benzinga
Topics Cannabis
News headline image
CBD's Toxicity Concerns: Could Europe Ban Cannabidiol In Cosmetics? ↗
September 23, 2024
Via Benzinga
News headline image
Avicanna Secures Nearly $2M In Private Placement Deal Amid US Patent Win For Cannabinoid Topical Formula ↗
August 29, 2024
Via Benzinga
Topics Intellectual Property
News headline image
Avicanna Secures US Patent For Topical Cannabinoid Technology To Treat Pain And Inflammation ↗
August 27, 2024
Via Benzinga
Topics Intellectual Property
News headline image
Avicanna's CBG Products Reach 19 Countries: Denmark Joins Global Expansion ↗
August 15, 2024
Via Benzinga
News headline image
Avicanna Q2 Revenue Improves 85% YoY, Cannabis Company Touts Two Successful Trials On Drug Candidates ↗
August 15, 2024
Via Benzinga
Topics Cannabis
News headline image
Latest Cannabis Hires And Board Changes, Here's What You Need To Know ↗
July 12, 2024
Via Benzinga
Topics Cannabis
News headline image
Avicanna Exports Cannabinoids To Singapore Legally — Even Though Cannabis Is Punishable By Death In The Country ↗
July 11, 2024
Via Benzinga
Topics Cannabis
News headline image
Life Science Virtual Investor Forum Presentations Now Available for Online Viewing
June 21, 2024
From Virtual Investor Conferences
Via GlobeNewswire
News headline image
Life Sciences Virtual Investor Forum Agenda Announced for June 20th
June 18, 2024
From Virtual Investor Conferences
Via GlobeNewswire
News headline image
CBD-Focused Avicanna Reports First-Ever Adjusted EBITDA Positive Quarter, 451% YoY Spike In Q1 Record Revenue ↗
May 14, 2024
Via Benzinga
News headline image
CBD Helps With This Rare Blistering Skin Disorder, New Study From Avicanna Shows Promising Results In Epidermolysis Bullosa Treatment ↗
May 13, 2024
Via Benzinga
Topics Cannabis
News headline image
Cannabinoid-Based Products Maker Sees Triple-Digit Growth In 2023 Gross Profit, Revenue Surges 314% YoY ↗
April 02, 2024
Via Benzinga
Topics Cannabis

Frequently Asked Questions

Is Avicanna Inc publicly traded?
Yes, Avicanna Inc is publicly traded.
What exchange does Avicanna Inc trade on?
Avicanna Inc trades on the OTC Traded
What is the ticker symbol for Avicanna Inc?
The ticker symbol for Avicanna Inc is AVCNF on the OTC Traded
What is the current price of Avicanna Inc?
The current price of Avicanna Inc is 0.0709
When was Avicanna Inc last traded?
The last trade of Avicanna Inc was at 10/22/26 03:24 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap